Screening Asymptomatic Patients With Diabetes for Unknown Coronary Artery Disease: an Open-label Randomized Study Comparing Exercise Testing Strategy With Management Based on Pharmacological/Behavioral Treatment of Traditional Risk Factors
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Coronary Artery Disease
- Sponsor
- TURRINI FABRIZIO
- Enrollment
- 400
- Locations
- 1
- Primary Endpoint
- Death and myocardial infarction
- Status
- Completed
- Last Updated
- 13 years ago
Overview
Brief Summary
In the present study a cohort of diabetic patients without any symptoms and without known coronary artery disease (CAD) will be screened at the investigators' diabetes outpatients services. Those with intermediate or high risk will be asked to participate and enrolled. They will be seen and followed by the cardiologists in order to provide the best adherence to medical therapy. By mean of a randomization process, a group of patients will undergo an exercise electrocardiography (ECG) testing while the other group will continue to be regularly seen at the investigators' cardiology service. Those patients with a positive exercise ECG test will be study by coronary angiography and treated according to the severity of coronary lesions by percutaneous stenting or surgery. Both groups of patients will be seen every six-eight months for the next three years.
Investigators
TURRINI FABRIZIO
Turrini fabrizio MD
Azienda Unita' Sanitaria Locale Di Modena
Eligibility Criteria
Inclusion Criteria
- •Type two Diabetes Mellitus
- •Cardiovascular risk equal or higher than 10% according to Italian risk score (www.cuore.iss.it)
Exclusion Criteria
- •Known coronary artery disease
- •Symptomatic heart failure
- •Objective inability to perform treadmill exercise
- •Known or active malignancy, advanced renal failure (clearance \< 25 ml/mi/1.73m2), liver cirrhosis (child Pugh III); stroke within the past 30 days
- •Presence of left bundle branch block or ST depression at rest greater than 0.9 mm
Outcomes
Primary Outcomes
Death and myocardial infarction
Time Frame: three years
Secondary Outcomes
- Symptomatic heart failure(three years)